Consulting | Strategic Organization | MyCardium AI

MyCardium AI Strategic Growth Consulting

A strategic consulting case for an AI cardiac imaging startup, focused on market penetration, business model upgrade, product development, funding logic, and KPI-based implementation.

Back to Portfolio

Recommendation

Upgrade the product and business model to accelerate clinical and international expansion

The case identifies MyCardium AI's strong technical position in cardiac imaging AI, but also highlights two strategic constraints: limited market penetration and a narrow business model. The recommended option is to upgrade both product functionality and revenue architecture, using subscription services, value-added solutions, clinical pilots, international channels, and KPI monitoring to build a more defensible growth path.

Strategic Issues

Market penetration remains limited: products are mainly tested in selected UK research centres and have not yet reached broad clinical market coverage.
The business model relies heavily on software services and has not fully connected internal resources with external market demand.
Weak market expansion could slow growth, reduce scale effects, and expose the company to competitors with more flexible offerings.

Strategic Options

Option 1: strengthen the existing strategy by deepening current AI and clinical cooperation advantages, improving service quality, and expanding through reputation.
Option 2: upgrade the product and business model by adding intelligent diagnostic functions, improving interface usability, introducing subscriptions and value-added services, and expanding international sales channels.
The recommended route is Option 2 because it improves value, rarity, imitation barriers, and organisational alignment under the VRIO logic.

Three-Year Action Plan

First 6 monthsFocus R&D on 1CMR and EchoConfidence product upgrades, add intelligent diagnostic indicators, improve the user interface, and complete at least three rounds of pilot testing with clinical partners.

Months 7-12Pilot subscription and value-added service models, introduce customised solutions, and adjust monetisation logic based on market feedback.

Year 2Use funding to support marketing, channel development, key recruitment, team training, and organisational process optimisation.

Year 3Scale clinical and international channels, monitor product usage, renewal, customer satisfaction, revenue growth, profitability, and ROI through quarterly strategic reviews.

£3mSeries A funding target over 12-18 months

£150kproduct development and upgrade budget in the first 12 months

£80kmarketing and channel expansion budget from Year 2 to Year 3

£70kteam expansion and organisational optimisation budget

30%expected average annual sales growth assumption

90%+target renewal rate and customer satisfaction score

KPI System

Market & Product

Five or more new domestic hospital partnerships in Year 1.
At least one European and one North American channel partnership by Year 2.
Increase product usage by 20% and maintain conversion rate of 75% or above.

Finance & Organisation

Average annual sales revenue growth of approximately 30%.
Profit margin improvement of 15% by Year 3 and ROI of 25% or above.
Complete key-position recruitment by early Year 2 and achieve 90%+ process optimisation execution.